SCHEMBL24934728

SCHEMBL24934728

CC(=O)c1ccc(C(=O)Nc2ccc(C)cc2)c(F)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.56
RAB9A P51151 9/20 0.56
SNCA P37840 1/20 0.51
SMN1; SMN2 Q16637 6/20 0.50
KMT2A Q03164 3/20 0.49
LMNA P02545 3/20 0.49
MAPT P10636 2/20 0.49
F2 P00734 1/20 0.49
F10 P00742 1/20 0.49
PLG P00747 1/20 0.49
PLAU P00749 1/20 0.49
PLAT P00750 1/20 0.49
AKR1C3 P42330 1/20 0.49
AKR1C2 P52895 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
MEN1 O00255 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
HDAC1 Q13547 2/20 0.48
HTT P42858 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13348769 0.82 F10 (0.52) NPC1RAB9ASNCASMN1; SMN2KMT2A
SCHEMBL24935800 0.82 NPC1 (0.49) NPC1RAB9ASNCASMN1; SMN2KMT2A
SCHEMBL6562864 0.79 MAOB (0.46) NPC1RAB9ASMN1; SMN2MAPTAKR1C3
SCHEMBL10178435 0.79 MAPT (0.51) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL8361564 0.78 NPC1 (0.68) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL13348752 0.78 MAPT (0.52) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL13719113 0.77 RAB9A (0.85) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL6490621 0.77 NPC1 (0.53) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL17664551 0.76 MEN1 (0.56) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL13581604 0.76 MEN1 (0.83) NPC1RAB9ASMN1; SMN2KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4119546-A1 BIFUNCTIONAL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Suzhou Kintor Pharmaceuticals, Inc. (CN) 2023-01-18 EP disclosed